COMO BIOTECH ApS: Financial statements 2012
CVR: 25349512
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
COMO BIOTECH ApS (CVR 25349512) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 71,528 and a net result of DKK -32,644. The profit margin was -45.6%. Equity in the 2012 report amounted to DKK 172,403. The solvency ratio was 60.1%.
- Revenue
- DKK 71,528
- Gross Profit
- DKK 25,906
- Profit/Loss
- DKK -32,644
- Equity
- DKK 172,403
- Total Assets
- DKK 286,904
Keep an eye on COMO BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 24, 2012, Jørn Frederik Falch has joined the board of directors of COMO BIOTECH ApS.
As of May 24, 2012, Lars Henning Stigel has left the board of directors of COMO BIOTECH ApS.
As of May 24, 2012, Michael Toft Overgaard is registered as chairman of COMO BIOTECH ApS.
About COMO BIOTECH ApS
COMO BIOTECH ApS was a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2000. The company has been dissolved on 11 April 2018. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2011). In 2016, the company reported a gross profit of DKK -31,752 and a net result of DKK -37,624 compared with DKK -23,560 the year before. Equity in the 2016 report amounted to DKK 171,507.